UW-Milwaukee professors Dr. Jessica Rotier and Dr. Osvaldo Jhonatan Sepulveda Villet turned a back-of-the-napkin idea into a startup that’s now on the path toward FDA approval.
Their innovation, SequiDose, is a syringe-based delivery platform designed to streamline IV medication administration. The device is built to hold prefilled, sealed doses—supplied by pharmaceutical manufacturers—which are pierced in sequence by a specially designed internal plunger, allowing multiple medications or flushes to be delivered through a single connection. The goal: reduce the risk of infection, improve efficiency for nurses, and ultimately enhance patient outcomes. With support from UW-Milwaukee Research Foundation, the team is pursuing federal funding and long-term commercialization plans.
Brian Walsh, Senior Technology Commercialization Manager at the UWM Research Foundation, worked closely with Rotier and Sepulveda Villet to help the professors begin the pathway to commercializing their innovation.